Application 207506
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AUROVELA 1/20 | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL-21 | 0.02MG;1MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 65862-939 | Aurovela 1/20 | Norethindrone Acetate and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-939 | Aurovela 1/20 | Norethindrone Acetate and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-939 | Aurovela 1/20 | Norethindrone Acetate and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-939 | Aurovela 1/20 | Norethindrone Acetate and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-939 | Aurovela 1/20 | Norethindrone Acetate and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-939 | Aurovela 1/20 | Norethindrone Acetate and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |